Not Yet RecruitingPhase 4ACTRN12610001018000

Misoprostol versus Oxytocin as prophylaxes against intraoperative and postoperative bleeding in cesarean section

Sponsor

Ain Shams University

Enrollment

220 participants

Start Date

Dec 1, 2010

Study Type

Interventional

Conditions

bleeding in cesarean section

Summary

To compare the efficacy of rectally administrated Misoprostol vs. intravenous Oxytocin infusion during and after cesarean sections to control intraoperative and postoperative bleeding.

Eligibility

Sex: FemalesMin Age: 15 YearssMax Age: 45 Yearss

Plain Language Summary

Simplified for easier understanding

This study compares two medications, misoprostol and oxytocin, for preventing excessive bleeding during and after planned cesarean section deliveries. It is for women aged 15 to 45 having a scheduled cesarean who do not have risk factors for heavy bleeding.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

600 microgram misoprostol (3 tablets) administrated rectally, right after induction of anesthesia.

Locations(1)

Cairo, Egypt

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12610001018000